acquired
Stage
4
Investors
About
Clementia is a biopharmaceutical company developing treatments for rare diseases.
Explore Clementia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Clementia is a biopharmaceutical company developing treatments for rare diseases.
Funding rounds, investor list, and risk signals — unlock with a subscription.